Case Type: Mergers & Acquisitions

Select Bancorp, Inc. (SLCT) relating to its proposed merger with First Bancorp (FBNC). Under the terms of the agreement, SLCT shareholders will receive 0.408 shares of FBNC per share they own.

Fintech Acquisition Corp. IV (FTIV) relating to its proposed acquisition of Perella Weinberg Partners. Under the terms of the agreement, FTIV will acquire Perella through a reverse merger, with Perella emerging as a publicly traded company.

Roman DBDR Tech Acquisition Corp. (DBDR) relating to its proposed acquisition of CompoSecure Holdings, LLC. Under the terms of the agreement, DBDR will acquire CompoSecure through a reverse merger, with CompoSecure emerging as a publicly traded company.

Strongbridge Biopharma plc (SBBP) relating to its proposed acquisition by Xeris Pharmaceuticals, Inc. Under the terms of the agreement, SBBP shareholders will receive 0.7840 shares of Xeris per share they own. SBBP shareholders will also receive one contingent value right, worth up to $1.00 in cash per share or equivalent Xeris stock upon achievement of … Read more

MMA Capital Holdings, Inc. (MMAC) relating to its proposed acquisition by an affiliate of Fundamental Advisors LP. Under the terms of the agreement, MMAC shareholders will receive $27.77 in cash per share they own.

Cimarex Energy Co. (XEC) relating to its proposed merger with Cabot Oil & Gas Corp. Under the terms of the agreement, XEC shareholders will receive 4.0146 shares of Cabot per share they own.

Enterprise Financial Services Corp. (EFSC) relating to its proposed acquisition by First Choice Bancorp (FCBP). Under the terms of the agreement, FCBP shareholders will receive 0.6603 shares of EFSC per share they own.

Montes Archimedes Acquisition Corp. (MAAC) relating to its proposed merger with Roivant Sciences. Under the terms of the agreement, MAAC will acquire Roivant through a reverse merger, with Roivant emerging as a publicly traded company.

TWC Tech Holdings II Corp. (TWCT) relating to its proposed merger with Cellebrite DI Ltd. Under the terms of the agreement, TWCT will acquire Cellebrite through a reverse merger, with Cellebrite emerging as a publicly traded company.

Soaring Eagle Acquisition Corp. (SRNG) relating to its proposed merger with Ginkgo Bioworks, Inc. Under the terms of the agreement, SRNG will acquire Ginkgo through a reverse merger, with Ginkgo emerging as a publicly traded company.